About Cellogen Therapeutics
Cellogen Therapeutics is a company based in Delhi (India) founded in 2021 by Gaurav Kharya. Cellogen Therapeutics has raised $2.81 million across 2 funding rounds from investors including Natco Pharma. The company has 1 employees as of April 05, 2024. Cellogen Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Delhi, India
- Employees 1 as on 05 Apr, 2024
- Founders Gaurav Kharya
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cellogen Therapeutics Private Limited
- Date of Incorporation 08 Jun, 2021
- Jurisdiction Dadri, Uttar Pradesh, India
-
Annual Revenue
$2.4 K (USD)0as on Mar 31, 2023
-
Net Profit
-$8.19 K (USD)52.84as on Mar 31, 2023
-
EBITDA
-$10.93 K (USD)51.79as on Mar 31, 2023
-
Total Equity Funding
$2.81 M (USD)
in 2 rounds
-
Latest Funding Round
$885.59 K (USD), Seed
Apr 25, 2025
- Investors
-
Employee Count
1
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cellogen Therapeutics
Cellogen Therapeutics has successfully raised a total of $2.81M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $885.59 thousand completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cellogen Therapeutics
Cellogen Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Natco Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs and finished dosage forms are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for Cellogen Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellogen Therapeutics
Investment portfolio details for Cellogen Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellogen Therapeutics
Detailed financials for Cellogen Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellogen Therapeutics Comparisons
Peer comparison for Cellogen Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellogen Therapeutics
Cellogen Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Cellogen Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellogen Therapeutics
Complete news archive for Cellogen Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellogen Therapeutics
Cellogen Therapeutics was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Cellogen Therapeutics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Cellogen Therapeutics is a funded company, having raised a total of $2.81M across 2 funding rounds to date.
As of Apr 05, 2024, the latest employee count at Cellogen Therapeutics is 1.
Annual revenue of Cellogen Therapeutics is $2.4K as on Mar 31, 2023.
Cellogen Therapeutics was founded in 2021 in Delhi, India, within the biotechnology sector. CAR-T cell-based therapies are developed by the company to address cancer and metabolic diseases. Operations focus on research and therapeutic innovation, with services centered on advanced cell treatments. The founder, Gaurav Kharya, leads efforts in this domain, targeting global health challenges through localized expertise.
Cellogen Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Cellogen Therapeutics has 1 investor. Key investors include Natco Pharma.